ARTICLE | Clinical News
Lane Labs preclinical data
May 24, 1999 7:00 AM UTC
In a study of 24 mice with implanted tumors, oral treatment with 1 g/day of BeneFin reduced tumor growth by 30 percent versus controls. Untreated mice died by week 10 while 20 percent of treated mice survived 15 weeks. Data were presented at the American Society of Clinical Oncology meeting in Atlanta. ...